Picard Medical, Inc. stock analysis
Want to see PMI full AI Analyst Report?
Picard Medical, Inc. (PMI) Stock Price & Analysis
PMI Stock Chart & Stats
- Day’s Range
- $7.15 - $7.76
- 52-Week Range
- $2.65 - $208.00
- Previous Close
- $7.23
- Volume
- N/A
- Average Volume (3M)
- 358.68K
- Market Cap
- $17.80M
- Enterprise Value
- $16.71M
- Total Cash (Recent Filing)
- $38.00K
- Total Debt (Recent Filing)
- $878.00K
- Price to Earnings (P/E)
- ―
- Beta
- -2.21
- Next Earnings
- Nov 17, 2026 (Est.)
- EPS Estimate
- -1.5
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Gross Margin Improvement
Stronger revenue and gross margin indicate improving commercial traction and better economics per dollar of sales. If sustained, this combination can expand the contribution available to cover operating costs, support investment in vascular and interventional products, and improve future earnings potential.
Improved Balance Sheet
Lower leverage and positive equity reduce balance-sheet stress compared with prior periods and provide a more stable foundation for operations. This improvement may increase financial flexibility, lessen the burden of debt claims, and make future capital allocation more manageable.
Simplified Warrant Structure
Eliminating the outstanding warrants and associated contingent claims simplifies the capital structure and reduces uncertainty around future obligations. Although shares were issued, removing these instruments can make the equity base easier to understand and reduce warrant-related complexity.
Bears Say
Severe Ongoing Unprofitability
The company’s improved gross margin has not yet translated into sustainable profitability, as operating losses remain large and net margin is deeply negative. Continued losses can consume resources, limit internally funded growth, and require a substantial improvement in scale or cost structure.
Persistent Cash Burn
Materially negative operating and free cash flow means the business is not currently funding itself through operations. Persistent cash consumption can constrain product development and commercial expansion, while increasing reliance on external financing until outflows are materially reduced.
Financing Dependence And Dilution Risk
Convertible financing provides capital but creates potential dilution and reinforces dependence on outside funding while losses and cash burn continue. Future equity conversion or warrant issuance could expand the share base, while the one-year maturity adds pressure to improve funding access.
Picard Medical, Inc. News
PMI FAQ
What was Picard Medical, Inc.’s price range in the past 12 months?
What is Picard Medical, Inc.’s market cap?
When is Picard Medical, Inc.’s upcoming earnings report date?
How were Picard Medical, Inc.’s earnings last quarter?
Is Picard Medical, Inc. overvalued?
Does Picard Medical, Inc. pay dividends?
What is Picard Medical, Inc.’s EPS estimate?
How many shares outstanding does Picard Medical, Inc. have?
What happened to Picard Medical, Inc.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Picard Medical, Inc.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Picard Medical, Inc.
Picard Medical, Inc., through its associated companies, is dedicated to the entire process of medical device commercialization, from initial design and manufacturing to production, distribution, marketing, and sales. A key product in its portfolio is the SynCardia TAH, a sophisticated total artificial heart specifically engineered to supplant a failing human heart in individuals afflicted with advanced cardiac disease. The firm's market presence extends across the United States, Europe, and other international regions. Established in 2021, Picard Medical maintains its primary operations in Tucson, Arizona, functioning as a direct subsidiary of Hunniwell Picard I, Llc.
- Sector
- General
- Industry
- Medical - Devices
- CEO
- Richard Fang
- Employees
- 75
- Website
- www.picardmedical.com
- Address
- 1992 E Silverlake Road, Tucson, Arizona 85713, USA, Tucson, AZ, 85713, US
Picard Medical, Inc. (PMI) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 6 | 12 |
| Technical Analysis | 3 | 6 | 1 |
| Moving Averages | 1 | 0 | 11 |










